Search for: "IN RE BAYER HEALTHCARE" Results 1 - 20 of 103
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
14 Mar 2024, 10:07 am by admin
Last week, Bayer broke its Philadelphia losing streak, with a win in Kline v. [read post]
14 May 2019, 11:24 am by Lawrence B. Ebert
Cir. 2004); see also Bayer Healthcare Pharm., Inc. v.Watson Pharm., Inc., 713 F.3d 1369, 1376 (Fed. [read post]
23 Nov 2016, 8:15 am by Kelly Hyman
“Each of these lawsuits arise from the injuries Plaintiff sustained after being implanted with Essure, which is a permanent birth control device that is manufactured and distributed by Bayer by Bayer Corp., Bayer HealthCare LLC, Bayer Essure Inc., Conceptus Inc., Bayer Healthcare Pharmaceuticals, and Bayer A.G., the Plaintiff’s petition stated. [read post]
2 Mar 2015, 2:43 pm
.* The EPO: privileged and immune says the PresidentMerpel re-sinks her paws in the hot story of the decision that Hague Court of Appeal issued in the sadly famous proceedings in SUEPO v EPO [on which see her earlier post here]. [read post]
16 Feb 2015, 1:44 am
  * Bayer feels the pain: branded Naproxen can't invoke the territoriality principleKatfriend Marty Schwimmer reports on Belmora LLC v Bayer Consumer Care AG and Bayer Healthcare LLC, 1:14-cv-00847-GBL (EDVA Feb. 6, 2015), a recent US District Court for the Eastern District of Virginia ruling that deals with Article 6bis of the Paris Convention in the US as it applies to Bayer’s trade mark ‘FLANAX’. [read post]
20 Jan 2015, 11:46 am
Bayer Healthcare Pharma., Inc., 16 F.Supp.3d 1341 (N.D. [read post]
21 Nov 2014, 4:00 am by Paula Bremner
Examples of re-litigation No re-litigation – acceptance of case1 Generic1 Win -> Generic2 Win A recent example where a generic 1 win resulted in an “automatic” generic 2 win is the case of Bayer v Apotex 2014 FC 403. [read post]
30 Oct 2014, 9:51 am
Bayer Healthcare Pharmaceutical, Inc., No. 10–1695, 2013 WL 1289050 (W.D. [read post]
23 Jun 2014, 12:57 pm by Schachtman
ITERATIVE DISJUNCTIVE SYLLOGISM Basic propositional logic teaches that the disjunctive syllogism (modus tollendo ponens) is a valid argument, in which one of its premises is a disjunction (P v Q), and the other premise is the negation of one of the disjuncts: P v Q ~P­­­_____ ∴ Q See Irving Copi & Carl Cohen Introduction to Logic at 362 (2005). [read post]
2 Jun 2014, 11:59 am by Bruce Khula
  So much is made clear by the Sixth Circuit’s recent opinion in In re: Bayer Healthcare & Merial Ltd. [read post]
10 Mar 2014, 11:31 am
[Plaintiff] has failed to support his claim.In re Zyprexa Products Liability Litigation, 2009 WL 3596982, at *11 (E.D.N.Y. [read post]
21 Feb 2014, 8:53 am
”  In re Fosamax Products Liability Litigation, 2013 WL 174416, at *1 (S.D.N.Y. [read post]
9 Jan 2014, 1:37 pm
We’ve covered a lot of topics since we started DDLaw in late 2006. [read post]
19 Sep 2013, 9:53 am by Bexis
., 712 F.3d 60 (1st Cir. 2013) – all of which also travel under the heading, In re Neurontin Marketing and Sales Practices Litigation. [read post]
5 Jul 2013, 5:00 am by Bexis
  Thus, in In re Zyprexa Products Liability Litigation, 489 F. [read post]